https://www.selleckchem.com/products/rg-7112.html
BACKGROUND Symptomatic intracranial stenosis was perceived to convey a high risk of recurrent stroke, but two previous trials (SAMMPRIS and VISSIT) did not show superiority of intracranial stenosis stenting over intensive medical management alone. These findings were partly due to a lower than expected risk of recurrent stroke without stenting, possibly reflecting the young age of recruits (median age less then 60 years), and raise questions about generalisability to routine clinical practice. We therefore studied the age-specific preva
Curtir
Comentario
Compartilhar
